We also found that increased expression of MAO-A is a feature of breast tumor cell lines that have acquired anticancer drug resistance and the tumors of patients that experienced poor RFS, implying that MAO-A expression might be of prognostic value in BC. The gene discussed is MAOA; the disease is breast cancer.